Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | PRKCA | P17252 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | CYP17A1 | P05093 | 3/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL686175 | 0.92 | ALDH1A1 (0.38) | ALDH1A1MEN1KMT2ANPSR1MAPT | |
| SCHEMBL14727765 | 0.88 | PRKCA (0.34) | ALDH1A1MEN1KMT2ANPSR1MAPT | |
| SCHEMBL14731097 | 0.88 | ALDH1A1 (0.31) | ALDH1A1MEN1KMT2ANPSR1MAPT | |
| SCHEMBL14727756 | 0.82 | NPSR1 (0.34) | ALDH1A1MEN1KMT2ANPSR1MAPT | |
| SCHEMBL18232664 | 0.82 | ALDH1A1 (0.40) | ALDH1A1MEN1KMT2ANPSR1MAPT | |
| SCHEMBL2601744 | 0.81 | ALDH1A1 (0.47) | ALDH1A1MEN1KMT2ANPSR1MAPT | |
| SCHEMBL14727757 | 0.78 | ALDH1A1 (0.47) | ALDH1A1NPSR1HSD11B1 | |
| SCHEMBL17425999 | 0.77 | ALDH1A1 (0.33) | ALDH1A1MEN1KMT2ANPSR1MAPT | |
| SCHEMBL15853229 | 0.77 | ALDH1A1 (0.37) | ALDH1A1MEN1KMT2ANPSR1MAPT | |
| SCHEMBL785727 | 0.76 | ALDH1A1 (0.36) | ALDH1A1MEN1KMT2ANPSR1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8741544-B2 | Salt, photoresist composition and method for producing photoresist pattern | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-06-03 | — | — | US | disclosed |
| US-20130052588-A1 | SALT, PHOTORESIST COMPOSITION AND METHOD FOR PRODUCING PHOTORESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130052588-A1 | SALT, PHOTORESIST COMPOSITION AND METHOD FOR PRODUCING PHOTORESIST PATTERN | RER1, COL1A1, H1-0 | ALDH1A1 1936/4885MEN1 3252/4885KMT2A 1351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.